Divi's Laboratories has informed that a meeting of Board of Directors of the Company is scheduled to be held on Saturday, August 01, 2026, to consider and approve unaudited standalone and consolidated financial results of the Company for the quarter ended June 30, 2026. As intimated earlier, the Trading Window for dealing in securities of the Company has been closed from July 01, 2026 till 48 hours after declaration of the financial results for the quarter ended June 30, 2026. Thus, the Trading window shall remain closed till August 03, 2026.
The above information is a part of company’s filings submitted to BSE.
